drugset / Trial / NCT02644876

Preventive Effects of Penehyclidine Hydrochloride Inhalation on Postoperative Pulmonary Complications

NCT02644876

Phase 4 Completed 864 enrolled Peking University First Hospital
RandomizedParallel-groupQuadruple-blindPrevention

Summary

Postoperative pulmonary complications (PPCs) are major causes of postoperative morbidity, mortality, and prolonged hospital stay.The incidence of PPCs may be as high as 41% to 75% in high-risk patients. Bronchodilator is frequently used in high-risk patients to prevent PPCs. Penehyclidine is a new anticholinergic agent which selectively block M1 and M3, but not M2 receptors. A pilot study of the investigators showed that prophylactic penehyclidine inhalation reduced the incidence of bronchospasm and the use of aminophylline in elderly patients after long-duration surgery. The purpose of this study is to investigate whether prophylactically penehyclidine inhalation could decrease the incidence of PPCs in high-risk patients after major intrathoracic and upper intraabdominal surgery.

Timeline

Start
2015-09-01
Primary completion
2018-11-08
Completion
2018-12-10

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Penehyclidine Small molecule 0.5 mg Inhaled

Indications

No indication recorded.